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Chronic kidney disease in African American and Mexican
American populations.
African Americans and Mexican Americans suffer from
disproportionately high rates of end-stage renal disease in com-
parison with whites from the United States. An improved un-
derstanding of both classic and novel chronic kidney disease risk
factors among racial/ethnic minorities may help to facilitate im-
proved prevention, screening, and early intervention strategies
for all patients at risk for chronic kidney disease—not only in the
United States, but on a global level. The economic implications
are equally important to inform health policy recommendations
and ensure cost-effective allocation of limited resources.
Resumen
La incidencia de la insuficiencia renal cro´nica (IRC) continu´a
aumentando globalmente. La desproporcionada tasa de IRC en
los grupos raciales y e´tnicos minoritarios de los Estados Unidos
de Ame´rica, pone de manifiesto la necesidad de revalorar las es-
trategias de tratamiento actuales para un mejor manejo e iden-
tificacio´n de la IRC en estas comunidades. Proyecciones simi-
lares han sido reportadas mundialmente. La discrepancia entre
la frecuencia de IRC y las estrategias de tratamiento en estos
grupos se debe a mu´ltiples factores, muchos de ellos modifica-
bles. Entre ellos se encuentran factores atribuibles al individuo,
a los sistemas de salud y a una participacio´n limitada en ensayos
clı´nicos. Mientras que es desafortunado el que esta disparidad
persista, el abordaje comprensivo de los diversos factores socio-
culturales, biolo´gicos y del comportamiento que intervienen en
este problema, pudiera ser la clave para una aplicacio´n efectiva
de los avances cientı´ficos en la mejora de resultados clı´nicos
para todos los pacientes con IRC.
End-stage renal disease (ESRD) is one of the most
vivid examples of racial and ethnic disparities in health
outcomes in the United States (Fig. 1) [1]. The incidence
of ESRD is 4 times more common in African Americans
than in their white counterparts, with an adjusted inci-
dence of 988 per million in African Americans and 254
per million in whites [2]. For Hispanic and non-Hispanic
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whites, the incidence rates are 471 and 325 per million, re-
spectively. The excess numbers of minority patients with
ESRD (largely African American and Mexican Ameri-
can) not only create a substantial burden on their local
communities, but increase the estimated yearly cost to
the US ESRD system by over US $6 billion, which con-
tributed substantially to an estimated overall cost of US
$22 billion in 2001 (Fig. 2).
The estimated prevalence of reduced glomerular filtra-
tion rate (GFR) is most prevalent among non-Hispanic
whites, followed by non-Hispanic blacks, and least preva-
lent in Mexican Americans (Table 1) [3]. Even after ad-
justment for age, sex, history of diabetes, hypertension,
and hypertensive medication, non-Hispanic blacks were
still less likely to have moderately decreased kidney func-
tion than non-Hispanic whites [3]. It is unclear which fac-
tors (modifiable and nonmodifiable) along the chronic
kidney disease (CKD) continuum lead to such a disparate
incidence of ESRD despite similar or lower rates of early
stages of CKD among racial/ethnic minorities.
CKD RISK FACTORS IN AFRICAN AMERICANS
AND MEXICAN AMERICANS
Diabetes mellitus and hypertension account for nearly
75% of the new cases of ESRD in the United States [2].
The age-adjusted prevalence of diabetes in the United
States varies by race and ethnicity, with Native Ameri-
cans and Alaskan Natives reported as having the highest
prevalence of diabetes in the United States (19%), fol-
lowed by non-Hispanic blacks (15%), Hispanics (14%),
and non-Hispanic whites (7%) [4]. By contrast, hyper-
tension is most prevalent among African Americans
(33.5%), followed by non-Hispanic whites (28.9%) and
Hispanics (20.7%). Despite having a lower prevalence of
hypertension, the control rate of hypertension is dramat-
ically lower in Hispanics (17.7%) compared with blacks
(28.1%) and whites (33.4%) [5]. The combination of
higher prevalence rates and poorer control of these major
risk factors likely contributes, in part, to the more rapid
S-137
S-138 Tareen et al: Chronic kidney disease in minorities
1000
750
500
250
0
Odds ratio
Ref Ref
White Black Native
American
Asian Non-
Hispanic
Hispanic
1 3.89 2.74 1.56 1 1.45
USRDS Annual Data Report 2003; adjusted for age
and gender.
*
*
*
*
*P < .0001
Fig. 1. ESRD incidence rate per million by race/ethnicity, 2001.
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Fig. 2. Estimated fiscal impact of ESRD costs in 2001 due to “excess”
ESRD rates among African Americans and Hispanics.
progression of CKD to ESRD among African Americans
and Mexican Americans in the United States.
Although DM and hypertension are the primary causes
of most ESRD cases, the influence of socioeconomic sta-
tus, lifestyle, and other clinical factors may contribute to
much of the excess risk of ESRD among minorities [6].
Moreover, these factors may also influence the expression
of emerging biologic and genetic factors that may con-
tribute to the increased risk of CKD/ESRD [7]. Two key
components of “socioeconomic” factors include poverty
level and education. These directly and indirectly influ-
ence access to health care and often correlate with adher-
ence to health recommendations, exposure to environ-
mental toxins, and other adverse health markers. African
American and Mexican American communities suffer
from excess rates of both poverty and low educational
attainment [8]. To evaluate the possible contribution of
educational attainment and poverty, we performed a pre-
liminary analysis of the association of these 2 factors with
proteinuria, an early marker of CKD.
METHODS
The Third National Health and Nutrition Examina-
tion Survey (NHANES III) was conducted by the Na-
tional Center for Health Statistics at 89 survey locations
between 1988 and 1994 [9]. The survey was a cross-
sectional, nationally representative sample of the US
civilian, noninstitutionalized population. NHANES III
used a stratified, multistage probability cluster design
with oversampling of Mexican Americans, African Amer-
icans, and persons over 60 years of age. The survey con-
sisted of multiple components, including a household
interview, a physical examination, and laboratory tests.
We limited our sample to 16,458 people over the age of
20 years for whom 24-hour urinary protein excretion data
were available. Respondents were asked to identify them-
selves as white, black, Mexican American, or other. We
excluded those individuals (N = 625) identified as other
race for this analysis. The survey began with a 1-hour
home visit for a household interview, during which infor-
mation on demography, socioeconomic status, medical
history, nutrition history, and family history was obtained
by trained interviewers and recorded in the data collec-
tion form [10]. This preliminary study consisted of uni-
variate analyses of race and ethnicity by federal poverty
level (FPL) (<200% vs. ≥200%) and education (<high
school vs. ≥high school). Urinary protein excretion was
categorized as microalbuminuria [urinary albumin excre-
tion (lg/mg) = 30–300 mg/day] or macroalbuminuria [uri-
nary albumin excretion (lg/mg) >300 mg/day].
RESULTS
Overall, less-than-high-school education was strongly
associated with the presence of microalbuminuria [rel-
ative risk (RR) = 1.4, confidence interval (CI) = 1.2–
1.5, P < 0.001] and macroalbuminuria (RR = 2.4, CI =
1.9–3.0, P < 0.001). Similarly, below-the-200% FPL was
associated with the presence of both microalbuminuria
(RR = 1.4, CI = 1.2–1.5, P < 0.001) and macroalbumin-
uria (RR = 1.8, CI = 1.4–2.2, P < 0.001). In compar-
ison with non-Hispanic whites, blacks had higher rates
of both microalbuminuria and macroalbuminuria at less-
than-high-school education and below-the-200% FPL.
However, the differences were less but still significantly
different at the higher levels. Hispanics had similar rates
of microalbuminuria, and macroalbuminuria at less-than-
high-school education. Hispanics with below-the-200%
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Table 1. Estimated prevalence of normal and decreased kidney function (GFR categories) by race/ethnicity in adults aged 20 years and older,
NHANES III, 1988 to 1994
Overall Estimated prevalence of GFR category (mL/min/1.73 m2)
Number of participants U.S. population Normal (90) Mild (60–89) Moderate (30–59) Severe (15–29)
Total 15,600a 100.0 64.3 (0.8) 31.2 (0.8) 4.3 (0.2) 0.20 (0.03)
Race/Ethnicity
Non-Hispanic white 6635 76.4 (1.3) 59.7 (1.0) 35.2 (0.9) 4.8 (0.3) 0.21 (0.03)
Non-Hispanic black 4163 10.9 (0.6) 79.2 (1.1) 17.4 (0.9) 3.1 (0.2) 0.25 (0.08)b,c
Mexican American 4185 5.1 (0.4) 85.4 (0.6) 13.5 (0.6) 1.0 (0.1)
Abbreviations are: GFR, glomerular filtration rate; NHANES III, Third National Health and Nutrition Examination Survey. GFR estimated using the simplified
Modification of Diet in Renal Disease study formula. Values expressed as percentage (standard error) unless noted otherwise.
aExcludes individuals with an estimated GFR <15 mL/min/1.73 m2 (0.2% of the population).
bEstimate is based on less than 30 individuals.
cCells with less than 10 observations.
FPL had higher rates of microalbuminuria, whereas the
prevalence of macroalbuminuria was similar.
DISCUSSION
The results of this preliminary analysis show influ-
ence of both level of educational attainment and level of
poverty on the prevalence of proteinuria, a key marker
of CKD and CKD progression. Although the prevalence
of CKD by estimated GFR is lower among minorities
[3], the prevalence of elevated serum creatinine has been
reported to be higher among African Americans than
non-Hispanic whites among NHANES participants [11].
At the 15-year examination of 3554 participants in the
Coronary Artery Risk Development in Young Adults
study, the adjusted odds of an elevated creatinine level
among black men were 11.4-fold that of white men, and
1.5-fold greater for black women than for white women
[12]. By contrast, the lower rates of CKD by both es-
timated GFR and serum creatinine level among Mexi-
can Americans—the predominant Hispanic group in the
NHANES study—may not be representative of the en-
tire Hispanic population. In a preliminary subset analysis
of 4844 persons in the Hispanic Health and Nutrition Ex-
amination Survey, Rodriguez et al reported higher levels
of serum creatinine (1.02 ± 0.02 vs. 0.92 ± 0.01 and 0.90
± 0.004 mg/dL) and a higher prevalence of estimated
GFR <60 mL/min/1.73 m2 (13% vs. 4% and 3%) for
Cuban Americans living in Florida compared with Mex-
ican Americans living in the Southwest U.S. and Puerto
Ricans living in the New York area, respectively [13].
After adjustment for demographic characteristics, socioe-
conomic status, and comorbid conditions, Cuban Ameri-
cans had nearly 4-fold [odds ratio (OR) = 3.81, 95% CI =
2.32–6.25] higher risk of having a lower estimated GFR
than Mexican Americans, and Puerto Ricans had an al-
most 50% higher risk (OR = 1.49, CI = 1.14–1.95) of
having a lower estimated GFR than Mexican Americans.
More African Americans (67%) and Hispanics (20%)
live in areas of urban poverty in the United States than
whites (12%); this may contribute to the racial and eth-
nic disparities in CKD [14]. Similarly, the proportion of
nonelderly African American and Hispanic populations
considered to be below the federal poverty level (US
$14,128 for a family of 3 in 2001) was 31% and 29%,
respectively, compared with only 11% of the white popu-
lation [8]. The results from our study support those from
other studies that have identified socioeconomic factors
such as low income, poor education, residence in a low-
income area, and poor access to health care as strong
predictors for the development and progression of CKD
[15, 16]. This is not surprising, given our findings of the
strong association with proteinuria, a powerful predictor
of decline in kidney function.
CONCLUSION
Both poverty and low levels of educational attainment
were strongly associated with an increased prevalence of
both microalbuminuria and macroalbuminuria. This as-
sociation was important regardless of race or ethnicity;
however, there was a stronger association among African
Americans and Mexican Americans. The higher preva-
lence of poverty and low levels of educational attainment
in minority communities appear to be important mod-
ifiers of CKD risk factors and likely play an important
role in the excessive rates of CKD in minority popula-
tions. Understanding the mechanisms that underlie these
factors as well as other social-cultural factors can cre-
ate new insights into improved prevention and screening
strategies in high-risk populations, and can be translated
to all persons at risk for CKD both in the United States
and globally.
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